Return to Index
Anakinra May Help Ease the Pain of Rheumatoid Arthritis
How Does Anakinra Work?
How Should I Take This Medication?
What Are the Side Effects?
- Infections (anakinra suppresses the immune system)
- Flu-like symptoms
- Abdominal pain
- Low white blood cell count
Who Should Not Take Anakinra?
- Have a fever or think you may have an infection
- Are taking certain medications, including tumor necrosis factor (TNF) blockers, such as adalimumab, etanercept, or infliximab
- Are allergic to proteins made from bacteria cells or any ingredient in the medication
- Have a latex allergy
- Have asthma, HIV infection, or kidney disease
- Are pregnant or breastfeeding
- Telling your doctor or dentist that you are taking anakinra before you have a procedure
- Talking to your doctor before you have a live virus vaccine
Arthritis Foundation http://www.arthritis.org
US Food and Drug Administration http://www.fda.gov
The Arthritis Society http://www.arthritis.ca
Canadian Pharmacists Association http://www.pharmacists.ca
Anakinra. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated June 4, 2013. Accessed October 13, 2014.
Biologic disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis. EBSCO DynaMed website. Available at: http://www.ebscohost.com/dynamed. Updated October 8, 2014. Accessed October 13, 2014.
Bresnihan, B, Alvara-Gracia, JM, Cobby, M, et al. Treatment of rheumatoid arthritis with recombinant human IL-1 receptor antagonist. Arthritis Rheum. 1998; 41:2196.
Fleischmann, RM, Schechtman, J, Bennett, R, et al. Anakinra, a recombinant human interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis: A large, international, multicenter, placebo-controlled trial. Arthritis Rheum. 2003; 48:927.
- Reviewer: Michael Woods, MD
- Review Date: 09/2014
- Update Date: 10/13/2014